UNSPSC 51292205: Mosapride

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I8MFJ1C0BY. European Medicines Agency schedules Mosapride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09074MIG. Mosapride generally arises in the molecular formula C21H25CLFN3O3.

UNSPSC 51292205 Mosapride is a Commodity code covering pharmaceutical products, though recent state and local solicitations under this code tag procurement of naloxone and drug deactivation systems for community health and public safety initiatives. State and local governments are using this code to acquire medications and medical countermeasures that support overdose response and substance-abuse prevention programs operated by county health departments and public health agencies. The issuing bodies pursuing this code are county-level health and public-safety authorities focused on emergency preparedness and community health resilience.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. The contract carries a two-year initial term with a one-year renewal option and includes standard compliance requirements such as E-Verify, drug-free workplace certification, and commercial general liability insurance. Vendors must include all shipping and delivery costs in their proposals and submit bids electronically through the county's e-Procurement Portal. The procurement is potentially funded through FEMA, which introduces additional federal compliance obligations including adherence to the Clean Air Act and Federal Water Pollution Control Act. This represents the primary recent activity visible under this code in state and local markets.